BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 32015686)

  • 1. TFAP2A Induced ITPKA Serves as an Oncogene and Interacts with DBN1 in Lung Adenocarcinoma.
    Guoren Z; Zhaohui F; Wei Z; Mei W; Yuan W; Lin S; Xiaoyue X; Xiaomei Z; Bo S
    Int J Biol Sci; 2020; 16(3):504-514. PubMed ID: 32015686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TFAP2A Induced KRT16 as an Oncogene in Lung Adenocarcinoma via EMT.
    Yuanhua L; Pudong Q; Wei Z; Yuan W; Delin L; Yan Z; Geyu L; Bo S
    Int J Biol Sci; 2019; 15(7):1419-1428. PubMed ID: 31337972
    [No Abstract]   [Full Text] [Related]  

  • 3. TFAP2A potentiates lung adenocarcinoma metastasis by a novel miR-16 family/TFAP2A/PSG9/TGF-β signaling pathway.
    Xiong Y; Feng Y; Zhao J; Lei J; Qiao T; Zhou Y; Lu Q; Jiang T; Jia L; Han Y
    Cell Death Dis; 2021 Apr; 12(4):352. PubMed ID: 33824285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ITPKA Gene Body Methylation Regulates Gene Expression and Serves as an Early Diagnostic Marker in Lung and Other Cancers.
    Wang YW; Ma X; Zhang YA; Wang MJ; Yatabe Y; Lam S; Girard L; Chen JY; Gazdar AF
    J Thorac Oncol; 2016 Sep; 11(9):1469-81. PubMed ID: 27234602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TFAP2A-induced SLC2A1-AS1 promotes cancer cell proliferation.
    Cui Y; Zhang C; Ma S; Guan F
    Biol Chem; 2021 May; 402(6):717-727. PubMed ID: 33580997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High expression of keratin 6C is associated with poor prognosis and accelerates cancer proliferation and migration by modulating epithelial-mesenchymal transition in lung adenocarcinoma.
    Hu HB; Yang XP; Zhou PX; Yang XA; Yin B
    Genes Genomics; 2020 Feb; 42(2):179-188. PubMed ID: 31768767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. STRIP2, a member of the striatin-interacting phosphatase and kinase complex, is implicated in lung adenocarcinoma cell growth and migration.
    Qiu LM; Sun YH; Chen TT; Chen JJ; Ma HT
    FEBS Open Bio; 2020 Mar; 10(3):351-361. PubMed ID: 31901223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional role of inositol-1,4,5-trisphosphate-3-kinase-A for motility of malignant transformed cells.
    Windhorst S; Kalinina T; Schmid K; Blechner C; Kriebitzsch N; Hinsch R; Chang L; Herich L; Schumacher U; Mayr GW
    Int J Cancer; 2011 Sep; 129(6):1300-9. PubMed ID: 21792881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synaptotagmin 12 (SYT12) Gene Expression Promotes Cell Proliferation and Progression of Lung Adenocarcinoma and Involves the Phosphoinositide 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Pathway.
    Liu K; Luo J; Shao C; Ren Z; Sun S; Zhu Y; Zhou H; Jiang Z; Li X; Gu W; Xu Y; Qiang Y; Ren B; Xu L; Wu H; Shen Y
    Med Sci Monit; 2020 Feb; 26():e920351. PubMed ID: 32108133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SLC39A5 promotes lung adenocarcinoma cell proliferation by activating PI3K/AKT signaling.
    Liu Z; Hu Z; Cai X; Liu S
    Pathol Res Pract; 2021 Aug; 224():153541. PubMed ID: 34252710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RHOV promotes lung adenocarcinoma cell growth and metastasis through JNK/c-Jun pathway.
    Zhang D; Jiang Q; Ge X; Shi Y; Ye T; Mi Y; Xie T; Li Q; Ye Q
    Int J Biol Sci; 2021; 17(10):2622-2632. PubMed ID: 34326698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HCP5 is a SMAD3-responsive long non-coding RNA that promotes lung adenocarcinoma metastasis via miR-203/SNAI axis.
    Jiang L; Wang R; Fang L; Ge X; Chen L; Zhou M; Zhou Y; Xiong W; Hu Y; Tang X; Li G; Li Z
    Theranostics; 2019; 9(9):2460-2474. PubMed ID: 31131047
    [No Abstract]   [Full Text] [Related]  

  • 13. Overexpression of RCC2 Enhances Cell Motility and Promotes Tumor Metastasis in Lung Adenocarcinoma by Inducing Epithelial-Mesenchymal Transition.
    Pang B; Wu N; Guan R; Pang L; Li X; Li S; Tang L; Guo Y; Chen J; Sun D; Sun H; Dai J; Bai J; Ji G; Liu P; Liu A; Wang Q; Xiao S; Fu S; Jin Y
    Clin Cancer Res; 2017 Sep; 23(18):5598-5610. PubMed ID: 28606921
    [No Abstract]   [Full Text] [Related]  

  • 14. Plakophilin-2 accelerates cell proliferation and migration through activating EGFR signaling in lung adenocarcinoma.
    Hao XL; Tian Z; Han F; Chen JP; Gao LY; Liu JY
    Pathol Res Pract; 2019 Jul; 215(7):152438. PubMed ID: 31126818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mex3a interacts with LAMA2 to promote lung adenocarcinoma metastasis via PI3K/AKT pathway.
    Liang J; Li H; Han J; Jiang J; Wang J; Li Y; Feng Z; Zhao R; Sun Z; Lv B; Tian H
    Cell Death Dis; 2020 Aug; 11(8):614. PubMed ID: 32792503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulation of 1D-myo-inositol 1,4,5-trisphosphate 3-kinase A protein expression in oral squamous cell carcinoma.
    Kato H; Uzawa K; Onda T; Kato Y; Saito K; Nakashima D; Ogawara K; Bukawa H; Yokoe H; Tanzawa H
    Int J Oncol; 2006 Apr; 28(4):873-81. PubMed ID: 16525636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-147b promotes lung adenocarcinoma cell aggressiveness through negatively regulating microfibril-associated glycoprotein 4 (MFAP4) and affects prognosis of lung adenocarcinoma patients.
    Feng YY; Liu CH; Xue Y; Chen YY; Wang YL; Wu XZ
    Gene; 2020 Mar; 730():144316. PubMed ID: 31884109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TFAP2A activates HMGA1 to promote glycolysis and lung adenocarcinoma progression.
    Zhao J; Lan G
    Pathol Res Pract; 2023 Sep; 249():154759. PubMed ID: 37586214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LDH-A promotes malignant behavior via activation of epithelial-to-mesenchymal transition in lung adenocarcinoma.
    Hou XM; Yuan SQ; Zhao D; Liu XJ; Wu XA
    Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30509961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High core 1β1,3-galactosyltransferase 1 expression is associated with poor prognosis and promotes cellular radioresistance in lung adenocarcinoma.
    Chen Y; Ji Y; Shen L; Li Y; Ren Y; Shi H; Li Y; Wu Y
    J Cancer Res Clin Oncol; 2024 Apr; 150(4):214. PubMed ID: 38662050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.